Skip to content

Haemonetics HAE Debt-to-assets

Debt-to-assets at other companies

Abbott logo
AbbottABT
0.3×+0.1×
TFX
TeleflexTFX
0.4×+0.1×
Boston Scientific logo
Boston ScientificBSX
-0.3×
Medtronic logo
MedtronicMDT
0.3×0.0×
LivaNova logo
LivaNovaLIVN
0.1×-0.1×
ICU Medical logo
ICU MedicalICUI
0.3×-0.1×

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's debt-to-assets?
Haemonetics (HAE) reported debt-to-assets of 0.5× in Q1 2026.
How has Haemonetics's debt-to-assets changed year-over-year?
Haemonetics's debt-to-assets increased by 1.6% year-over-year, from 0.5× to 0.5×.
What is the long-term trend for Haemonetics's debt-to-assets?
Over 5 years (2021 to 2026), Haemonetics's debt-to-assets has grown at a 4.5% compound annual growth rate (CAGR), from 0.4× to 0.5×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.